Gen Sobue

Nagoya University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by the expansion of the polyglutamine tract in the androgen receptor (AR). Motor neurons (MNs) derived from patient-specific induced pluripotent stem cells (iPSCs) robustl y recapitulated early SBMA phenotypes driven by endogenous mutant AR in the absence of testosterone (dihydrotestosterone) and detectable mutant AR aggregation. Notably, endoplasmic reticulum stress markedly exacerbated SBMA pathology. Cross-species integrative analyses of patient-derived neurons and spinal cords of transgenic mouse models revealed high expression of multiple disease-associated neuropeptides, including urotensin II (UTS2), in patient spinal MNs that was correlated with disease onset and progression in iPSC-derived MNs. Downstream signaling analyses of these neuropeptides revealed convergent molecular pathways whose pharmacological inhibition rescued cellular phenotypes. Together, these results establish a human disease model harboring endogenous mutant AR that closely reproduces early SBMA pathology and provides molecular leads for elucidating disease mechanisms and biomarkers and developing therapeutic targets.

Year:

2025

To elucidate the molecular basis of multiple system atrophy (MSA), a neurodegenerative disease, we conducted a genome-wide association study (GWAS) in a Japanese MSA case/control series followed by replication studies in Japanese, Korean, Chinese, European, and North American samples. In the GWAS stage, rs2303744 on chromosome 19 showed a suggestive association ( P = 6.5 × 10 − 7 ) that was replicated in additional Japanese samples ( P = 2.9 × 10 − 6 , odds ratio (OR) = 1.58; 95% confidence interval (CI), 1.30–1.91), and then confirmed as highly significant in a meta-analysis of East Asian population data ( P = 5.0 × 10 − 15 , OR = 1.49; 95% CI 1.35–1.65). The association of rs2303744 with MSA remained significant in combined European/North American samples ( P = 0.017, OR = 1.12; 95% CI 1.02–1.23) despite allele frequencies being quite different between these populations. rs2303744 leads to an amino acid substitution in PLA2G4C that encodes the cPLA2γ lysophospholipase/transacylase. The cPLA2γ-Ile143 isoform encoded by the MSA risk allele has significantly decreased transacylase activity compared with the alternate cPLA2γ-Val143 isoform, and may perturb membrane phospholipids and promote oligodendroglial pathology.

Year:

2024

Year:

2022

Collaborators (18)

Sonja Scholz

National Institute of Neurological Disorders and Stroke

UNITED STATES
View details

Hideyuki Okano

Dean and Professor

Keio University School of Medicine

JAPAN
View details

Yuichi Riku

Aichi Medical University

JAPAN
View details

Yohei Okada

Professor

Aichi Medical University

JAPAN
View details

Ken Yamamoto

Professor

Kurume University

JAPAN
View details

Henry Houlden

Professor of Neurogenetics

-

UNITED KINGDOM
View details

Tatiana Foroud

Department Chair

Indiana University

UNITED STATES
View details

yasushi iwasaki

Professor

Aichi Medical University

JAPAN
View details

Ullrich Wüllner

University of Bonn

GERMANY
View details

Osamu Onodera

Professor

Niigata University

JAPAN
View details

Akinobu Ota

Professor

Kinjo Gakuin University

JAPAN
View details

Tatsushi Toda

University of Tokyo

JAPAN
View details

Virginia M-Y Lee

Professor

University of Pennsylvania

UNITED STATES
View details

Shoji Tsuji

Professor

International University of Health and Welfare

JAPAN
View details

Emil Gustavsson

Assistant Research Professor

University of Cambridge

UNITED KINGDOM
View details

Shinichi Morishita

Project Professor

University of Tokyo

JAPAN
View details

Masahisa Katsuno

Dean

Nagoya University

JAPAN
View details

Kazuya Kawabata

Senior Assistant Professor

Fujita Health University

JAPAN
View details